![]() ![]() We believe that this innovative business model will have global impact and implications. As Moderna expands internationally, we are delighted to bring mRNA manufacturing to Canada. This article provides a summary of those interim recommendations you may access the full guidance document here. While we are still responding to this pandemic, we also want to ensure we and society learn from it. The WHO Strategic Advisory Group of Experts on Immunization (SAGE) has issued updated interim recommendations for the use of the Moderna COVID-19 (mRNA-1273) vaccine against COVID-19. “As a company, we are committed to global public health. ![]() We recently announced data from the final analysis of the Phase COVE study demonstrating that vaccination with the Moderna COVID-19 vaccine showed 93% efficacy, with this efficacy remaining durable six months after administration of the second dose,” said Stéphane Bancel, CEO of Moderna, in the press release. The main trials showed that the originally authorised vaccine has a high efficacy in all age groups. “I would like to thank the Government of Canada for the partnership they have built with us and for their faith in our data, science, and early confidence in our mRNA platform in addressing the COVID-19 pandemic. Data have shown that originally authorised Spikevax and its adapted vaccines cause the production of antibodies against SARS-CoV-2 that can protect against COVID-19. Moderna is also in discussion with other governments for potential collaborations built on a similar model, the company stated in a press release. Under the MoU, Moderna and Canada aim to build a foundation on which Canada can have direct access to pandemic response capabilities as well as access to vaccines Moderna is developing against respiratory viruses, including COVID-19, seasonal influenza, respiratory syncytial virus (RSV), and potential other vaccines, pending licensure. ![]() The company signed a memorandum of understanding (MoU) with the government of Canada for the facility. 10, 2021, Moderna announced that it plans to build a messenger RNA (mRNA) vaccine manufacturing facility in Canada that will include access to the company’s mRNA development technology. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |